Former SVP and Franchise Head for US Oncology at Jazz Pharmaceuticals, with established track record for leading a portfolio of products spanning ...

All the latest breaking news on United States. Browse ibtimes archives of photos, videos and articles on United States.

It will be good to see Harry, he’s a popular boy and the players will be keen to see and meet up with him.” There had been a growing belief amongst the fanbase that United could sign him ...

It does not necessarily reflect the view of The Herald. STAND-IN Southend United skipper Harry Taylor says tomorrow’s clash with Altrincham is a six pointer for the Shrimpers. Tenth placed Blues ...

Manchester United have stepped up their efforts to sign a striker who humbled Harry Maguire in February, although the Red Devils could yet sign Viktor Gyokeres instead if one condition is met.

Harry Maguire and Manuel Ugarte sat out training on Wednesday and look set to miss Manchester United’s Europa League trip to Real Sociedad. Ruben Amorim’s men are looking to bounce back from ...

United’s lengthy list of absentees has grown ahead of facing La Real on Thursday, with defender Maguire and midfielder Ugarte missing training on the eve of the game with minor injuries ...

SILVER SPRING, Md. & RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, announced today that James Edgemond, Chief ...

LGT Fund Management Co Ltd. acquired a new stake in United Therapeutics Co. (NASDAQ:UTHR – Free Report) during the 4th quarter, according to its most recent disclosure with the Securities and ...

HC Wainwright reissued their buy rating on shares of United Therapeutics (NASDAQ:UTHR – Free Report) in a report published on Thursday morning,Benzinga reports. HC Wainwright currently has a $ ...

United Therapeutics stock opened at $319.96 on Thursday. United Therapeutics has a 12-month low of $221.53 and a 12-month high of $417.82. The company has a market capitalization of $14.28 billion ...

Leerink analyst Roanna Ruiz lowered the firm’s price target on United Therapeutics (UTHR) to $420 from $430 and keeps an Outperform rating on the shares. United Therapeutics’ Q4 earnings ...